Scinovex
review Open AccessTop 1% cited

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Leukemia · 2022 · Vol. 36(7) · pp. 1720–1748
Rita AlaggioCatalina AmadorIoannis AnagnostopoulosAyoma D. AttygalleIguaracyra AraújoEmilio BertiGovind BhagatAnita BorgesDaniel F. BoyerMaria CalaminiciAmy ChadburnJohn K. C. ChanWah CheukWee Joo ChngJohn ChoiShih‐Sung ChuangSarah E. CouplandMagdalena CzaderSandeep S. DavéDaphne de JongMing‐Qing DuKojo S.J. Elenitoba‐JohnsonJudith A. FerryJulia T. GeyerDita GratzingerJoan GuitartSumeet GujralMarian H. HarrisChristine J. HarrisonSylvia HartmannAndreas HochhausPatty M. JansenKennosuke KarubeWerner KempfJoseph D. KhouryHiroshi KimuraWolfram KlapperAlexandra E. KovachShaji KumarAlexander J. LazarStefano LazziLorenzo LeonciniNelson LeungVasiliki LeventakiXiao‐Qiu LiMegan S. LimWeiping LiuAbner LouissaintAndrea N. MarcoglieseL. Jeffrey MedeirosMichael MichalRoberto N. MirandaChristina MitteldorfSantiago Montes‐MorenoWilliam G. MoriceValentina NardiKikkeri N. NareshYasodha NatkunamSiok‐Bian NgIlske OschliesGerman OttMarie ParrensMelissa PulitzerS. Vincent RajkumarAndy C. RawstronKaren L. RechAndreas RosenwaldJonathan SaidClémentine SarkozyShahin SayedCaner SayginAnna SchuhWilliam A. SewellReiner SiebertAliyah R. SohaniReuben ToozeAlexandra Traverse‐GlehenFrancisco VegaB. VergierAshutosh WechalekarBrent L. WoodLuc XerriWenbin Xiao

Abstract

We herein present an overview of the upcoming 5<sup>th</sup> edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4<sup>th</sup> edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5<sup>th</sup> edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.

Lymphoma Diagnosis and TreatmentViral-associated cancers and disordersChronic Lymphocytic Leukemia ResearchPathologyLymphomaLymph nodeHistiocyteMyeloidListing (finance)MedicineCancer research

MeSH terms

HumansLymphomaWorld Health OrganizationHematologic Neoplasms

Funding

  • World Health Organization
  • Centre International de Recherche sur le Cancer
Citations
3,466
FWCI
472.29
field-weighted impact
References
335
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.